Melanoma Risk-Reduction Among Patients and Family Members
Completed
- Conditions
- Melanoma
- Interventions
- Behavioral: QuestionnaireBehavioral: Interview
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 170
- Registration Number
- NCT00510302
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Gleevec Study for Patients With Ovarian Cancer
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 73
- Registration Number
- NCT00510653
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Primary Breast Cancer Occurring Concomitant With Pregnancy
Early Phase 1
Completed
- Conditions
- Breast CancerPregnancy
- Interventions
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 61
- Registration Number
- NCT00510367
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Combined Colon and Endometrial Cancer Screening in Women With HNPCC
Completed
- Conditions
- Colon Cancer
- Interventions
- Behavioral: Interview
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT00510796
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Irinotecan (Camptosar) in Patients With Advanced Sarcomas
- First Posted Date
- 2007-08-01
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 38
- Registration Number
- NCT00509860
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00509600
- Locations
- 🇺🇸
UT MD . Anderson Cancer Center, Houston, Texas, United States
Phase I Trial of ZIO-101 in Patients With Solid Tumors
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 47
- Registration Number
- NCT00509782
- Locations
- 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Folfox-B Study for Patients With Colorectal Liver Metastases
Phase 2
Terminated
- Conditions
- Colorectal Liver Metastases
- Interventions
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT00508872
- Locations
- 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
Phase 1
Terminated
- Conditions
- Glioblastoma Multiforme
- Interventions
- Dietary Supplement: Hominex-2
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2012-01-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00508456
- Locations
- 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Iressa Study in Patients With Salivary Gland Cancer
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT00509002
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath